Global Maternal Blood Test Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Maternal Blood Test market size was valued at US$ 4566 million in 2024 and is forecast to a readjusted size of USD 7882 million by 2031 with a CAGR of 8.2% during review period.

A maternal blood test is a type of prenatal screening test that determines the likelihood that a chromosome disorder will impact a pregnancy or certain behavioural issues will impact a pregnancy. The primary goal of the test is to ensure that the baby does not have any chromosomal abnormalities such as Down syndrome. These tests are known to be capable of providing more information about pregnancy health.

Maternal blood tests can detect and diagnose chromosomal rearrangements, X-linked diseases, and help reduce spontaneous abortions, improve implantation rates, prevent trisomy offspring, and avoid the risk of spreading monogenic diseases. However, PGS and PGD results are not 100% accurate, and if necessary, diagnostic tests such as amniocentesis and CVS must be performed after pregnancy to confirm a positive PGS/PGD result. Rising usage of maternal blood testing is driving the market.

This report is a detailed and comprehensive analysis for global Maternal Blood Test market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Maternal Blood Test market size and forecasts, in consumption value ($ Million), 2020-2031

Global Maternal Blood Test market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Maternal Blood Test market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Maternal Blood Test market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Maternal Blood Test

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Maternal Blood Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CENTOGENE NV, SEQUENOM, Natera, Inc, LifeLabs Genetics, Sema4 OpCo, Inc, Invitae Corporation, Illumina, Inc, Thermo Fisher Scientific Inc, General Electric, PerkinElmer Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Maternal Blood Test market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Combined First Trimester Screening

Second Trimester Maternal Serum Screening

Market segment by Application

Edwards Syndrome

Patau Syndrome

Down syndrome

Neural Tube Defects

Other

Market segment by players, this report covers

CENTOGENE NV

SEQUENOM

Natera, Inc

LifeLabs Genetics

Sema4 OpCo, Inc

Invitae Corporation

Illumina, Inc

Thermo Fisher Scientific Inc

General Electric

PerkinElmer Inc

Agilent Technologies, Inc

F. Hoffmann-La Roche Ltd

YOURGENE HEALTH

Eurofins Scientific

EKF Diagnostics

BGI

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Maternal Blood Test product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Maternal Blood Test, with revenue, gross margin, and global market share of Maternal Blood Test from 2020 to 2025.

Chapter 3, the Maternal Blood Test competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Maternal Blood Test market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Maternal Blood Test.

Chapter 13, to describe Maternal Blood Test research findings and conclusion.